Free Newsletter
Pharma needs new blood to re-invent itself
The pharma industry should be re-inventing itself, "not re-trenching," the Association of the British Pharmaceutical Industry's director general, Dr. Richard Barker, said at the Economist conference this week. A key element of that re-invention? Bringing new talent into the insular pharma world from outside the industry. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: